Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 11,053,296	$ 14,629,295
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	103,936	(334,449)
Realized investment gains, net	(1,026,768)	(451,590)
Change in fair value of equity securities	(15,033,564)	(17,738,388)
Unrealized trading losses included in income	0	0
Amortization of cost of insurance acquired	307,083	317,908
Provision for deferred income taxes	3,237,621	3,756,282
Depreciation and depletion	757,782	789,739
Stock-based compensation	13,974	299,314
Charges for mortality and administration of universal life and annuity products	(2,703,990)	(2,737,821)
Interest credited to account balances	1,736,139	1,794,213
Change in accrued investment income	124,419	10,282
Change in reinsurance receivables	590,423	697,801
Change in policy liabilities and accruals	(2,112,376)	(2,173,115)
Change in income taxes receivable	(215,485)	24,563
Change in other assets and liabilities, net	(1,146,472)	(325,402)
Net cash used in operating activities	(4,313,982)	(1,441,368)
Proceeds from investments sold and matured:
Fixed maturities available for sale	5,500,000	5,000,000
Equity securities	3,344,765	4,813,238
Trading securities	0	102,699
Mortgage loans	2,005,832	1,844,701
Notes receivable	403,484	754,667
Real estate	88,151	2,503,900
Policy loans	564,552	680,012
Short-term investments	1,000,000	22,500,000
Total proceeds from investments sold and matured	12,906,784	38,199,217
Cost of investments acquired:
Fixed maturities available for sale	(999,219)	0
Equity securities	(11,149,087)	(7,198,349)
Trading securities	0	(102,699)
Mortgage loans	(985,812)	(2,111,502)
Notes receivable	(1,318,133)	(800,000)
Real estate	(467,299)	(11,396,924)
Policy loans	(423,407)	(488,597)
Short-term investments	0	(950,925)
Total cost of investments acquired	(15,342,957)	(23,048,996)
Net cash (used in) provided by investing activities	(2,436,173)	15,150,221
Cash flows from financing activities:
Policyholder contract deposits	2,052,142	2,049,905
Policyholder contract withdrawals	(1,982,984)	(2,233,320)
Payments of principal on notes payable/line of credit	0	(19,000,000)
Purchase of treasury stock	(203,553)	(216,745)
Net cash used in financing activities	(134,395)	(19,400,160)
Net decrease in cash and cash equivalents	(6,884,550)	(5,691,307)
Cash and cash equivalents at beginning of period	45,263,967	41,185,196
Cash and cash equivalents at end of period	$ 38,379,417	$ 35,493,889